Finish Line or Beginning? Welcome the New Board-certified Surgical Oncologists Douglas S. TylerFabrizio Michelassi Healthcare Policy and Outcomes 24 February 2016 Pages: 1403 - 1408
2015 James Ewing Lecture: 75-Year History of the Society of Surgical Oncology—Part III: The Transformative Years (1991–2015) Charles M. BalchDaniel G. CoitRussell S. Berman Healthcare Policy and Outcomes 28 January 2016 Pages: 1409 - 1417
A New Technology for Sentinel Node Biopsy: A Logistic Improvement Sarah L. Blair Breast Oncology 18 February 2016 Pages: 1418 - 1419
Just Do It: Changing our Culture to Embrace Optimal Perioperative Venous Thromboembolism Chemoprophylaxis for Abdominal and Pelvic Cancer Patients Srinivas J. IvaturyStefan D. Holubar Healthcare Policy and Outcomes 24 February 2016 Pages: 1420 - 1421
Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis Andrei FagarasanuGhazi S. AlotaibiCynthia Wu Healthcare Policy and Outcomes 17 February 2016 Pages: 1422 - 1430
Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery Robert W. KrellChristopher P. ScallySamantha Hendren Healthcare Policy and Outcomes 13 November 2015 Pages: 1431 - 1439
An Evaluation of Postoperative Complications and Cost After Short-Stay Thyroid Operations Sumana NarayananDena ArumugamStanley Z. Trooskin Endocrine Tumors 01 December 2015 Pages: 1440 - 1445
Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1–T2 Well-Differentiated Thyroid Cancer Wouter P. KluijfhoutJesse D. PasternakInsoo Suh Endocrine Tumors 01 December 2015 Pages: 1446 - 1451
Regional Therapies for Advanced Cancer: Update for 2016 Kiran K. TuragaT. Clark GamblinDavid L. Bartlett Regional Therapies for Advanced Malignancies 05 January 2016 Pages: 1452 - 1453
Computerized System for Staging Peritoneal Surface Malignancies Paolo SammartinoDaniele BiacchiAngelo Di Giorgio Gastrointestinal Oncology Open access 12 November 2015 Pages: 1454 - 1460
Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery Rebecca A. MarmorKaitlyn J. KellyJoel M. Baumgartner Gastrointestinal Oncology 05 November 2015 Pages: 1461 - 1467
The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Shigeki KusamuraPilar Adriana Torres MesaMarcello Deraco Gastrointestinal Oncology 16 November 2015 Pages: 1468 - 1473
Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Chukwuemeka IhemelanduPaul H. Sugarbaker Gastrointestinal Oncology 23 November 2015 Pages: 1474 - 1480
Avoiding Diverting Ileostomy in Patients Requiring Complete Pelvic Peritonectomy Paul H. Sugarbaker Gastrointestinal Oncology 05 November 2015 Pages: 1481 - 1485
Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement Harveshp D. MogalEdward A. LevineKonstantinos I. Votanopoulos Gastrointestinal Oncology 16 November 2015 Pages: 1486 - 1495
Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment Sean JudgePeter ThomasBrian Loggie Gastrointestinal Oncology 06 November 2015 Pages: 1496 - 1500
Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results Paul SugarbakerChukwuemeka IhemelanduLana Bijelic Gastrointestinal Oncology 06 November 2015 Pages: 1501 - 1507
Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis Mediget TeshomeCaimiao WeiElizabeth A. Mittendorf Breast Oncology 18 February 2016 Pages: 1508 - 1514
Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients Rachel A. SanfordXiudong LeiMariana Chavez-MacGregor Breast Oncology 17 December 2015 Pages: 1515 - 1521
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy Paul BaronPeter BeitschPat Whitworth Breast Oncology Open access 29 December 2015 Pages: 1522 - 1529
Fertility Preservation for the Young Breast Cancer Patient Shari B. GoldfarbSabrina A. KamerMary L. Gemignani Breast Oncology 20 January 2016 Pages: 1530 - 1536
Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer Sylvia A. ReyesTari A. KingNina A. Bickell Breast Oncology 29 December 2015 Pages: 1537 - 1542
Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study Kaveh Borhani-KhomaniMaj-Lis Møller TalmanTove Filtenborg Tvedskov Breast Oncology 29 December 2015 Pages: 1543 - 1548
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes Emilia J. DiegoPriscilla F. McAuliffeGretchen M. Ahrendt Breast Oncology 04 January 2016 Pages: 1549 - 1553
Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database Adan Z. BecerraChristian P. ProbstFergal J. Fleming Colorectal Cancer 12 January 2016 Pages: 1554 - 1561
Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis Sung Uk BaeYoon Dae HanNam Kyu Kim Colorectal Cancer 29 December 2015 Pages: 1562 - 1568
Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer Tina FransgaardLau Caspar ThygesenIsmail Gögenur Colorectal Cancer 29 December 2015 Pages: 1569 - 1575
Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients Ignazio TarantinoFelix J. HüttnerAlexis Ulrich Colorectal Cancer 29 December 2015 Pages: 1576 - 1586
Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis Patrick L. WagnerFrances AustinHaroon A. Choudry Colorectal Cancer 07 January 2016 Pages: 1587 - 1593
Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? Pierre-Emmanuel ColomboMartin M. BertrandPhilippe Rouanet Colorectal Cancer 29 December 2015 Pages: 1594 - 1600
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer E. M. V. de CubaI. H. J. T. de HinghE. A. te Velde Colorectal Cancer Open access 04 January 2016 Pages: 1601 - 1608
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Joel M. BaumgartnerThomas G. KwongAndrew M. Lowy Gastrointestinal Oncology 17 December 2015 Pages: 1609 - 1617
Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei? Jean-Baptiste DelhormeDominique EliasDiane Goéré Gastrointestinal Oncology 17 December 2015 Pages: 1618 - 1624
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center Yang LiuHaruaki IshibashiYutaka Yonemura Gastrointestinal Oncology 30 December 2015 Pages: 1625 - 1631
Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands Marijn KoëterKevin ParryGrard A. P. Nieuwenhuijzen Gastrointestinal Oncology 04 January 2016 Pages: 1632 - 1638
Patterns and Predictors of Weight Loss After Gastrectomy for Cancer Jeremy L. DavisLuke V. SelbyVivian E. Strong Gastrointestinal Oncology 05 January 2016 Pages: 1639 - 1645
Ileal Augmentation Cystoplasty Combined with Ileal Ureter Replacement After Radical Treatment for Cervical Cancer In Gab JeongKyung-Sik HanBumsik Hong Gynecologic Oncology 29 December 2015 Pages: 1646 - 1652
Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma Caryn M. St. ClairAne Gerda Z. ErikssonMario M. Leitao Jr. Gynecologic Oncology 29 December 2015 Pages: 1653 - 1659
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) M. PetrilloP. De IacoA. Fagotti Gynecologic Oncology 29 December 2015 Pages: 1660 - 1665
What Should We Expect After a Complete Cytoreduction at the Time of Interval or Primary Debulking Surgery in Advanced Ovarian Cancer? Luis ChivaFernando LapuenteAntonio Gonzalez-Martin Gynecologic Oncology 29 December 2015 Pages: 1666 - 1673
Tracheal Autotransplantation for Functional Reconstruction of Extended Hemilaryngectomy Defects: A Single-Center Experience in 30 Patients Elke LoosJeroen MeulemansPierre Delaere Head and Neck Oncology 29 December 2015 Pages: 1674 - 1683
Microsurgical Reconstructions for Head and Neck Cancers in Elderly Aged >80 Years: An Analysis of Surgical Outcomes and Quality of Life E. O. F. DimovskaJ. J. ClibbonA. Figus Head and Neck Oncology 29 December 2015 Pages: 1684 - 1692
Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck Evan A. TserosVal GebskiMichael J. Veness Head and Neck Oncology 19 January 2016 Pages: 1693 - 1698
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients Andrea RuzzenenteMatteo FassanAlfredo Guglielmi Hepatobiliary Tumors 30 December 2015 Pages: 1699 - 1707
Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup Simone RiberoSimona Osella-AbatePietro Quaglino Melanomas 23 November 2015 Pages: 1708 - 1715
Prospective Randomized Study to Compare Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Therapeutic Lymph Node Dissection With or Without the Use of an Ultrasonic Scalpel Marie-Laure Matthey-GiéOlivier GiéMaurice Matter Melanomas 29 December 2015 Pages: 1716 - 1720
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study Sven-Petter HaugvikEva Tiensuu JansonHalfdan Sorbye Pancreatic Tumors 17 December 2015 Pages: 1721 - 1728
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds Zohra Ali-Khan CattsMuhammad Khurram BaigNicholas Petrelli Pancreatic Tumors 04 January 2016 Pages: 1729 - 1735
Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients Michael D. KlugerIrene EpelboymJohn A. Chabot Pancreatic Tumors 29 December 2015 Pages: 1736 - 1743
Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort Study André HennigsHannah BiehlJörg Heil Reconstructive Oncology 06 November 2015 Pages: 1744 - 1751
